Description
Invista 70mg Tablet is a medication containing the active ingredient Vildagliptin. It belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors. Vildagliptin works by increasing the levels of incretin hormones in the body. These hormones help to regulate blood sugar levels by stimulating the pancreas to release more insulin and reducing the amount of sugar produced by the liver, particularly after meals. This dual action helps to lower blood glucose levels in individuals with type 2 diabetes mellitus. Invista 70mg Tablet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It can be used as monotherapy or in combination with other antidiabetic medications such as metformin, sulfonylureas, or thiazolidinediones. The typical dosage is one 70mg tablet once daily. However, dosage should be determined by a healthcare professional based on individual patient needs and response. Common side effects may include hypoglycemia (low blood sugar), headache, dizziness, and gastrointestinal disturbances. It is important to inform your doctor about any pre-existing medical conditions, especially heart failure, and any other medications you are taking. Store Invista 70mg Tablet at room temperature, away from moisture and heat, and out of reach of children.
